Over the past few years, we have been deeply engaged in – and have closely observed – the rapid growth of Chinese biotech companies. Despite a challenging market environment, these companies have continued to make remarkable...more
In a time of shifting opinions on the benefits of globalization, China’s “One Belt, One Road” initiative (OBOR) offers an unexpected bright spot for multinational companies able and willing to participate in this...more
The era of globalization may not be over, but the post-World War II global trading regime is undergoing a period of stress last seen during the demise of the Bretton Woods exchange mechanism in the early 1970s. I. General...more